Top of the morning to you. Hope your day is getting off to a good start. This should be a busy one here at the Pharmalot corporate campus, where we expect to spend a great deal of time perusing documents. Meanwhile, we are celebrating the purchase of a shiny, new coffee kettle with a fresh cup of stimulation (the old one melted yesterday). Please join us. And, of course, here are a few tidbits to get you going. Have a great day and let us know if you hear anything interesting...
Biogen MS Drug Meets Goal Of Second Trial (Reuters)
Mylan Names Heather Bresch As CEO (Pittsburgh Business Times)
Medtronic Probes Hacking Into Insulin Pumps (Reuters)
Asthma Meds May Increase Attacks In Children (Reuters)
ACIP Recommends Diabetes Get Hepatitis B Vaccine (Reuters)
New Jersey Town Refunds $1.7M In Property Tax To Roche (Belleville Patch)
Novartis Alcon Unit Faces Fraud Probe (Reuters)
Hot Shower, Not Pain Patch, Led To Marine's Death (The Virginian Pilot)
Neglecting ABPI Code Is A 'Worrying Trend' (Pharma Times)
Merck Tries To Protect Unused Sewer Rights (Star-Ledger of NJ)
Celesio Plans Major Reorganization (Reuters)
EDITOR'S NOTE: Please check this post for updates throughout the morning
tea kettle thx to mirahartford on flickr
1 Comment
I've cobbled together a pretty hilarious graphic, to accompany my take on the story listed above -- on Merck's "Camp-Out" -- staking sewer water capacity permits, over the last 23 years at Whitehouse Station.
Do go take a look!
Namaste!